Molecular Partners Ag (MOLN) Total Liabilities (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Total Liabilities of $24526.2 for Q1 2026, down 100.0% year-on-year from $14.4 billion in Q1 2025, and up 89935.72% on a QoQ basis from $27.24 in Q4 2025.
Molecular Partners Ag (MOLN) Total Liabilities (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Total Liabilities for 7 consecutive years, with $24526.2 the latest figure, recorded in Q1 2026.
- Quarterly Total Liabilities fell 100.0% year-over-year to $24526.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24526.2 (down 100.0% YoY) and the FY2025 annual result came in at $27.24, down 100.0% from the prior year.
- Total Liabilities rose to $24526.2 in Q1 2026 per MOLN's latest filing, from $27.24 in the prior quarter.
- Over the last five years, Total Liabilities for MOLN reached as high as $51.3 billion in Q1 2022 and fell as low as $21.25 in Q2 2025.
- A 5-year average of $10.8 billion and a median of $28.1 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities fell 12.12% — and 2025, when it slumped 100.0%.
- Year by year, Total Liabilities stood at $28.1 million in 2022, then fell by 12.12% to $24.7 million in 2023, then decreased by 21.98% to $19.3 million in 2024, then plunged by 100.0% to $27.24 in 2025, then jumped by 89935.72% to $24526.2 in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $24526.2, $27.24, and $20778.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | 24,526.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,526.15 |
| Dec 31, 2025 | 27.24 |
| Sep 30, 2025 | 20,778.07 |
| Jun 30, 2025 | 21.25 |
| Mar 31, 2025 | 14.35 Bn |
| Dec 31, 2024 | 19.28 Mn |
| Sep 30, 2024 | 17.81 Bn |
| Jun 30, 2024 | 16.64 Mn |
| Mar 31, 2024 | 19.55 Bn |
| Dec 31, 2023 | 24.71 Mn |
| Sep 30, 2023 | 24.80 Bn |
| Jun 30, 2023 | 27.27 Mn |
| Mar 31, 2023 | 24.19 Bn |
| Dec 31, 2022 | 28.12 Mn |
| Sep 30, 2022 | 30.78 Bn |
| Jun 30, 2022 | 34.70 Mn |
| Mar 31, 2022 | 51.27 Bn |
| Dec 31, 2021 | 70.90 Mn |
| Sep 30, 2021 | 56.57 Bn |
| Dec 31, 2020 | 88.85 Mn |